Skip to main content

Advertisement

SpringerLink
Log in

Role of the hospital pharmacy and therapeutics committee in detecting and regulating off-label drug use

  • Letter to the Editor
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Durán-García E, Santos-Ramos B, Puigventos-Latorre F, Ortega A. Literature review on the structure and operation of Pharmacy and Therapeutics Committees. Int J Clin Pharm. 2011;33(3):475–83.

    Article  PubMed  Google Scholar 

  2. Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med. 2006;166:1021–6.

    Article  PubMed  Google Scholar 

  3. Conde-García M, Fernández-Feijoo M, Calleja-Hernández MA. Estudio de adecuación a la ficha técnica, efectividad, seguridad y coste del rituximab en un hospital de tercer nivel. Farm Hosp. 2009;33:305–11.

    Article  PubMed  Google Scholar 

  4. Vargas-Rivas JE, Montes-Casas MM, Cancela-Diez B, Martínez-Martínez F, Sabater-Hernández D, Calleja-Hernández MA. Estudio de adecuación a la ficha técnica de las prescripciones de Trastuzumab en un hospital de tercer nivel. Farm Hosp. 2011 (forthcoming).

  5. Vargas J, García B, Conde M, Jiménez A, Hernández J, Fernández MA. Compliance with prescription information sheet of trastuzumab prescriptions in a tertiary level Spanish hospital [Abstract]. Pharm World Sci. 2008;30:672–3.

    Google Scholar 

  6. Hiddemann W, Kneba M, Dreyling M, Schmitz N, Lengfelder E, Schmits R, et al. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood. 2005;106:3725–32.

    Article  PubMed  CAS  Google Scholar 

  7. Ferguson JSJ, Summerhayes M, Masters S, Schey S, Smith IE. New treatments for advanced cancer: an approach to prioritization. Br J Cancer. 2000;83:1268–73.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharm. D. Pharmaceutical Care Research Group, Grupo de Investigación en Atención Farmacéutica, University of Granada, Campus Universitario de Cartuja S/N, 18071, Granada, Spain

    Jaime E. Vargas-Rivas, Daniel Sabater-Hernández, Miguel A. Calleja-Hernández, María J. Faus & Fernando Martínez-Martínez

Authors
  1. Jaime E. Vargas-Rivas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel Sabater-Hernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Miguel A. Calleja-Hernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. María J. Faus
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fernando Martínez-Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jaime E. Vargas-Rivas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vargas-Rivas, J.E., Sabater-Hernández, D., Calleja-Hernández, M.A. et al. Role of the hospital pharmacy and therapeutics committee in detecting and regulating off-label drug use. Int J Clin Pharm 33, 719–721 (2011). https://doi.org/10.1007/s11096-011-9532-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-011-9532-z

Keywords

Search

Navigation